Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
| REGENERON PHARMACEUTICALS, INC. |
| MYLAN PHARMACEUTICALS INC. and CELLTRION, INC. |
| 24-1564 |
| March 13, 2024 |
| U.S. Court of Appeals, Federal Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 13, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 1 Appeal docketed. Received: 03/12/2024. [990362] Entry of Appearance is due on 03/27/2024. Certificate of Interest is due on 03/27/2024. Docketing Statement is due on 03/27/2024. Certified List is due on 04/22/2024. [JSP] [Entered: 03/13/2024 11:08 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
